Iovance Biotherapeutics Inc (IOVA)

Oct 09, 2026

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings - Zacks Investment Research

Oct 09, 2026

Oct 04, 2026

Iovance Biotherapeutics, Inc. (IOVA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 04, 2026

Oct 02, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research

Oct 02, 2026

Oct 02, 2026

Iovance Biotherapeutics (LSE:0JDK) Stock Forecast & Analyst Predictions - Simply Wall Street

Oct 02, 2026

Oct 01, 2026

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer - The Manila Times

Oct 01, 2026

Oct 01, 2026

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer - GlobeNewswire Inc.

Oct 01, 2026

Oct 01, 2026

Iovance's new medical chief led programs that helped drive a drug above $2 billion in annual sales. - Stock Titan

Oct 01, 2026

Sep 30, 2026

IOVA Stock Hits 52-Week High on Raised Revenue Outlook for 2026 - Zacks Investment Research

Sep 30, 2026

Sep 30, 2026

Iovance Biotherapeutics (IOVA) Surges 31.5%: Is This an Indication of Further Gains? - Zacks Investment Research

Sep 30, 2026

Sep 30, 2026

Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Forecast & Analyst Predictions - Simply Wall Street

Sep 30, 2026

Sep 21, 2026

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research

Sep 21, 2026

Sep 18, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Sep 18, 2026

Sep 18, 2026

Iovance Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Moomoo

Sep 18, 2026

Sep 10, 2026

Iovance Biotherapeutics' Chief Regulatory Officer Reports RSU Vesting and Tax Withholding Transactions - Kalkine Media

Sep 10, 2026

Sep 10, 2026

Iovance at Wells Fargo conference: sales momentum lifts outlook By Investing.com - Investing.com Australia

Sep 10, 2026

Sep 10, 2026

Iovance at Wells Fargo conference: sales momentum lifts outlook By Investing.com - Investing.com UK

Sep 10, 2026

Sep 09, 2026

Iovance Biotherapeutics (IOVA) Institutional Ownership 2026 - MarketBeat

Sep 09, 2026

Sep 08, 2026

Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? - Stocktwits

Sep 08, 2026

Sep 06, 2026

How Iovance Biotherapeutics Inc. (IOVA) Affects Rotational Strategy Timing - Stock Traders Daily

Sep 06, 2026

Sep 04, 2026

Iovance Biotherapeutics, Inc. (IOVA) Latest Press Releases & Corporate News - Yahoo Finance

Sep 04, 2026

Sep 04, 2026

Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewswire

Sep 04, 2026

Sep 03, 2026

NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 03, 2026

Sep 01, 2026

Iovance Biotherapeutics (IOVA) Stands Out with Strong Quant Rati - GuruFocus

Sep 01, 2026

Aug 29, 2026

Iovance Biotherapeutics (IOVA) Wins FDA Trial Clearance, Is The Stock Still 54% Undervalued? - sahmcapital.com

Aug 29, 2026

Aug 27, 2026

Iovance Biotherapeutics Inc. (IOVA) Peer Comparison – Compare with Others - Value Research

Aug 27, 2026

Aug 27, 2026

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen - Eastern Progress

Aug 27, 2026

Aug 22, 2026

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates - Eastern Progress

Aug 22, 2026

Aug 21, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Aug 21, 2026

Aug 21, 2026

Biotech company Iovance grants 20 new employees options with an $8.99 exercise price - Stock Titan

Aug 21, 2026

Aug 21, 2026

Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 5.8%Here's Why - MarketBeat

Aug 21, 2026

Aug 21, 2026

IOVA Stock Pulls Back As Biotech Momentum Cools - StocksToTrade

Aug 21, 2026

Aug 21, 2026

UBS Lifts Iovance Biotherapeutics Price Target as Cancer Drug Sales Top Expectations - TIKR.com

Aug 21, 2026

Aug 21, 2026

Iovance Biotherapeutics Stock Is Trending Friday: What's Going On? - Benzinga

Aug 21, 2026

Aug 20, 2026

Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? - TradingView

Aug 20, 2026

Aug 20, 2026

Iovance Biotherapeutics grants inducement stock options to 27 new employees - scanx.trade

Aug 20, 2026

Aug 20, 2026

IOVA Stock Hits Fresh 52-Week Peak On UBS Target Hike, Melanoma Sector Optimism - Yahoo Finance

Aug 20, 2026

Aug 20, 2026

Iovance Shares Rise 12.5% as Analyst Price Targets Lag Behind Rally - TechStock²

Aug 20, 2026

Aug 20, 2026

IOVA Stock Hits Fresh 52-Week Peak On UBS Target Hike, Melanoma Sector Optimism - Stocktwits

Aug 20, 2026

Aug 20, 2026

Iovance Biotherapeutics stock trends on sector momentum, Q2 beat - scanx.trade

Aug 20, 2026

Aug 20, 2026

Why Iovance Biotherapeutics Stock Hit 52-Week High - TradingView

Aug 20, 2026

Aug 20, 2026

IOVA Maintained by UBS -- Price Target Raised to $7.00 - GuruFocus

Aug 20, 2026

Aug 20, 2026

Iovance's Growth Outlook Clouded as Amtagvi Faces Competition Hurdles, UBS Says - marketscreener.com

Aug 20, 2026

Aug 20, 2026

META_TITLE_QUOTE - Yahoo Finance

Aug 20, 2026

Aug 20, 2026

IOVA Stock Climbs As Earnings Beat Fuels Guidance Rethink - StocksToTrade

Aug 20, 2026

Aug 20, 2026

Iovance Biotherapeutics (NASDAQ:IOVA) Marks Major Market Shift - Kalkine Media

Aug 20, 2026

Aug 20, 2026

Here's Why Iovance Biotherapeutics (IOVA) is a Great Momentum Stock to Buy - Yahoo Finance

Aug 20, 2026

Aug 20, 2026

Iovance Biotherapeutics: Breakout Quarter, Catalysts Ahead, And Competitor Updates (IOVA) - Seeking Alpha

Aug 20, 2026

Aug 20, 2026

UBS raises Iovance Biotherapeutics stock price target on revenue beat By Investing.com - Investing.com Canada

Aug 20, 2026

Aug 20, 2026

Iovance Biotherapeutics (NASDAQ:IOVA) Reaches New 12-Month HighWhat's Next? - MarketBeat

Aug 20, 2026

Aug 20, 2026

IOVANCE BIOTHERAPEUTICS INC : UBS RAISES TARGET PRICE TO $7 FROM $4 - webull.com

Aug 20, 2026